Corporate News
Date Published: 4th Mar 2015OBS Medical CEO – Peter Leyland, has been invited to attend this year’s 35th Annual Cowen Health Care Conference as a panel member for the Digital Therapeutics and Mobile Rx: Real World Applications and Emerging Business Models discussion.
Read More...Corporate News Product News
Date Published: 25th Feb 2015OBS Medical’s CEO – Peter Leyland will be presenting Visensia® – The Safety Index™ at Swiss Re – “Transforming Healthcare: Telemedicine, best practice and you” event on the 24th Feb 2015.
Read More...Corporate News
Date Published: 12th Dec 2014OBS Medical is pleased to announce its selection of Arazy Group Consultants Inc.’s – LICENSALE.COM™ technology to streamline the registration of Visensia® – The Safety Index™ for new and emerging markets.
Read More...Corporate News
Date Published: 21st Nov 2014OBS Medical will be piloting Visensia® Mobile, with the aim of improving patient safety and outcomes, through the early detection of patient deterioration as a result of the continuous monitoring of three key vital signs (Heart Rate, SpO2 and Respiration Rate)
Read More...